我如何治疗移植后的淋巴增殖性疾病
Jennifer E Amengual1, Barbara Pro1
1Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
Blood
|August 4, 2023
概括
移植后淋巴增殖性疾病 (PTLD) 是一种严重的移植并发症. 虽然一些患者通过降低免疫抑制得到改善,但像采用免疫疗法这样的新疗法对于耐药病例至关重要,特别是与爱斯坦-巴尔病毒 (EBV) 相关的病例.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 移植后淋巴增殖障碍 (PTLD) 是固体器官和造血干细胞移植 (HSCT) 后的一种重大,危及生命的并发症.
- PTLD的异质性和患者的免疫功能低下状态带来了相当大的治疗挑战,包括感染的风险.
- 单态PTLD和B细胞淋巴瘤构成了PTLD病例的大多数.
研究的目的:
- 审查PTLD目前的治疗策略.
- 突出管理PTLD的挑战,特别是高风险或耐火病例.
- 探索新的治疗途径,包括针对爱斯坦-巴尔病毒 (EBV) 的疗法和采用免疫疗法.
主要方法:
- 对关于PTLD治疗方式的现有文献的审查.
- 对响应适应的风险分层治疗方法的分析.
- 评估免疫抑制降低,免疫疗法和化疗的作用.
主要成果:
- 大约25%的PTLD患者不需要化疗,使用目前适应反应的策略.
- 高风险或耐药PTLD患者的结果仍然很差,这强调了需要新的治疗方法.
- 爱斯坦-巴尔病毒 (EBV) 涉及60-80%的PTLD病例,这表明针对EBV的疗法是有希望的.
结论:
- 目前的PTLD治疗涉及到一种多模式的方法,包括免疫抑制调整,免疫疗法和化疗.
- 收养免疫疗法代表了耐火性PTLD的一个有希望的选择,并可能在未来考虑早期的治疗线路.
- 对新型治疗方法的进一步研究对于改善具有挑战性的PTLD病例的结果至关重要.
相关概念视频
Kidney Transplant II: Surgical Procedure
36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kidney Transplant III: Nursing Management
39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557


